{"id":"W2561366385","doi":"10.1158/1538-7445.am2015-ct311","title":"Abstract CT311: Results of a phase I/IIa dose-escalation study of the combination of decitabine and genistein against advanced solid tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; Michelin (Canada); Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Decitabine; Medicine; Genistein; Pharmacology; Neutropenia; Pharmacokinetics; Maximum tolerated dose; Oncology; Hypomethylating agent; Phases of clinical research; Leukopenia; Internal medicine; Cancer; Chemotherapy; DNA methylation; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001657373,0.001911233,0.002031447,0.0005201371,0.0005526749,0.0007830962,0.0009504732,0.00126275,0.002567135],"category_scores_gemma":[0.0008605214,0.0005290381,0.0009214772,0.0005598985,0.0009496888,0.0005983727,0.0002714542,0.003426014,0.0008048782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001009067,"about_ca_system_score_gemma":0.001684552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001581473,"about_ca_topic_score_gemma":0.00238083,"domain_scores_codex":[0.999478,0.0002408734,0.00004063133,0.00008804946,0.00006244643,0.00009003338],"domain_scores_gemma":[0.9991561,0.0001581091,0.0001275601,0.00008725088,0.00007604295,0.0003949376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3707586,0.1284967,0.007873982,0.001355725,0.001535678,0.0008679087,0.0005349071,0.006740455,0.3891308,0.0003566136,0.00641133,0.0859374],"study_design_scores_gemma":[0.181618,0.7560855,0.01650387,0.00005215947,0.0006523196,0.0008477512,0.0000615198,0.001834337,0.03898489,0.0001573012,0.003154517,0.00004781676],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919192,0.001959059,0.0008188278,0.0003747027,0.00007411841,0.002038382,0.001433625,0.0001066184,0.001275454],"genre_scores_gemma":[0.9839014,0.001702015,0.002760525,0.0005569923,0.0001186551,0.001800026,0.005922428,0.00005543525,0.003182417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002567135,"threshold_uncertainty_score":0.008765101,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07540904835654774,"score_gpt":0.4265294050886609,"score_spread":0.3511203567321132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}